Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print

ChanTest Appoints Commercial Officer



Published August 17, 2012
Related Searches: Promotions & Moves Testing CRO Development
Chris Mathes, Ph.D., has been appointed chief commercial officer at ChanTest. Dr. Mathes will oversee all sales, marketing and customer relations activities. He will also contribute to strategic guidance of the company as a global player in the CRO industry.
 
"Chris is a real ion channel guy," said Dr. Arthur "Buzz" Brown, chief executive officer, president and founder of ChanTest. "As CCO, he brings a unique mix of science and business to our company in order to make ChanTest's interface to the world even better."
 
Dr. Mathes has published several ion channel papers in peer reviewed journals over the past two decades. In the last 10 years, Dr. Mathes has been a pioneer in the development and implementation of automated patch clamp systems for ion channel safety testing and drug discovery.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On